![Jason Adair](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jason Adair
Corporate Officer/Principal at Liquidia Technologies, Inc.
Net worth: 1 M $ as of 2024-06-29
Profile
Jason Adair's current job is Vice President-Corporate Development & Strategy at Liquidia Technologies, Inc. He started this position in 2016.
Mr. Adair's former job was Executive Director-Corporate Development at BioCryst Pharmaceuticals, Inc. He held this position from 2011 to 2015.
He also worked as Vice President-Corporate Development & Strategy at Liquidia Corp.Mr. Adair's education includes an undergraduate degree from Wake Forest University and an MBA from Tuck School of Business at Dartmouth.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
LIQUIDIA CORPORATION
0.15% | 2024-06-02 | 112,465 ( 0.15% ) | 1 M $ | 2024-06-29 |
Jason Adair active positions
Companies | Position | Start |
---|---|---|
Liquidia Technologies, Inc.
![]() Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Corporate Officer/Principal | 2016-01-13 |
Former positions of Jason Adair
Companies | Position | End |
---|---|---|
BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2015-11-30 |
LIQUIDIA CORPORATION | Investor Relations Contact | - |
Training of Jason Adair
Wake Forest University | Undergraduate Degree |
Tuck School of Business at Dartmouth | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
LIQUIDIA CORPORATION | Health Technology |
Private companies | 1 |
---|---|
Liquidia Technologies, Inc.
![]() Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Health Technology |
- Stock Market
- Insiders
- Jason Adair